Developer docs
API playgroundTry for free, no card

Search company profiles

Lucideon

Full company profile

uuid0008c8h

Namestring
Lucideon
Legal namestring
Lucideon Ltd
Websiteurl
lucideon.com
Company typeenum
Private
Founded yearint
1948
Descriptiontext

Lucideon is a UK-headquartered development and commercialization organization (DCO) specializing in materials science and technology services, operating from Staffordshire with a newer US facility in Greenville, South Carolina. The company is organized around two principal service lines: (1) medical device biocompatibility and biological testing — including cytotoxicity, extractables and leachables, toxicological risk assessment, and implant performance testing — delivered through its Greenville lab and an in vitro cell biology laboratory in Staffordshire developed with Queen Mary University of London; and (2) advanced ceramics development and characterization, covering ceramic additive manufacturing (in partnership with Hydra Manufacturing), nuclear waste container integrity testing, proprietary ceramic ink formulations, SNBSC and silicon carbide processing R&D, and fusion-energy-grade ceramics under UKAEA contracts. Technical differentiation rests on proprietary processing IP (e.g., viscous plastic processing of SiC achieving 86% theoretical density below 2000°C, SNBSC robocasting at 99.7% nitriding) and embedded positions within UK research infrastructure such as the £18.27m Midlands Industrial Ceramics Group and AMRICC Centre.

Lucideon monetizes primarily through professional services: testing fees for medical device regulatory compliance, government and institutional research contracts (UKAEA, UKNNL, ESA consortium), and collaborative materials development engagements with industrial clients in medical devices, aerospace, and nuclear sectors. The company has no publicly disclosed pricing; engagements are scoped and contracted per project. It sells through direct enterprise engagement with engineering and procurement teams, supplemented by technical presence at industry events such as Ceramics Expo USA and the Next Generation Industry Conference. Its customer base spans medical device manufacturers (primary segment), nuclear operators and government bodies, fusion energy research organizations, and aerospace/advanced manufacturers, with notable named engagements including Sellafield Ltd (via UKNNL), UKAEA, and an ESA-funded Metalysis-led titanium consortium. The company is privately held as Lucideon Ltd, with no parent company or institutional investor identified in the available data.

Short descriptiontext

Lucideon is a UK-based development and commercialization organization providing materials science services — including medical device biocompatibility testing and advanced ceramics development for nuclear, fusion, and aerospace clients — across facilities in Staffordshire and Greenville, South Carolina.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersStafford, United Kingdom
HQ citystring
Stafford
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
materials testing services, biocompatibility testing, advanced ceramics development, materials characterization, ceramic additive manufacturing
NAICS code4 codes
  • Testing Laboratories and Services54138
  • Testing Laboratories and Services541380
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Testing Laboratories8734
  • Services-Commercial Physical & Biological Research8731
Product category
Materials Testing and Development Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Biocompatibility Testing Services
TypeProfessional Services
Description

Comprehensive testing services for medical devices including cytotoxicity, extractables and leachables testing, toxicological risk assessment, and advanced implant performance assessments. Revenue generated through testing fees for regulatory compliance.

todaysmedicaldevelopments.com
2Research Contracts
TypeProfessional Services
Description

Government and institutional research contracts including work for UK Atomic Energy Authority under Fusion Futures Industry Capability Programme and UK National Nuclear Laboratory for nuclear industry testing.

niauk.org
3Materials Development and Consulting
TypeProfessional Services
Description

Collaborative materials development including ceramic additive manufacturing solutions and advanced ceramics development for specialized applications in aerospace and industrial manufacturing.

tctmagazine.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Lucideon is a development and commercialization organization that provides advanced materials testing, characterization, and development services. Its core offerings include medical device biocompatibility testing (cytotoxicity, extractables and leachables, toxicological risk assessment, implant performance) through laboratories in Greenville, SC and Staffordshire, UK, and advanced ceramics research covering ceramic additive manufacturing, nuclear waste container integrity testing, and fusion-energy ceramics for UKAEA. Revenue is generated primarily through project-based testing fees and collaborative materials development contracts with enterprise and government clients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Near-complete nitriding (99.7%) achieved for SNBSC ceramic materials via additive manufacturing
+1 more record
Product overview1 text field

Lucideon is an international technology company offering a portfolio of advanced materials testing and development services. The company operates two complementary core offerings: (1) medical device biocompatibility testing through its laboratories in Greenville, South Carolina and Staffordshire, UK, providing cytotoxicity, extractables and leachables testing, toxicological risk assessment, and implant performance assessments; and (2) advanced ceramics development including ceramic additive manufacturing solutions (via Hydra collaboration), nuclear waste container integrity testing, SNBSC kiln furniture materials, viscous plastic processing of silicon carbide, and fusion energy ceramics research for UKAEA. Additionally, Lucideon participates in the Metalysis ESA consortium for sustainable titanium production and supports the AMRICC Academy for ceramics sector training.

Product and service9 records
1Biocompatibility Testing Laboratory - Greenville
CategoryBiocompatibility Testing Services
Description

State-of-the-art facility in Greenville, South Carolina providing comprehensive medical device biocompatibility testing — including cytotoxicity, extractables and leachables testing, toxicological risk assessment, and advanced implant performance assessments — for medical device manufacturers needing to verify biological safety and meet FDA and international regulatory requirements.

2In Vitro Cell Biology Laboratory
CategoryBiocompatibility Testing Services
Description

Complementary in vitro cell biology laboratory in Staffordshire, UK, developed in partnership with Queen Mary University of London's School of Engineering and Materials Science, supporting advanced biological testing for medical device manufacturers.

3Ceramic Additive Manufacturing Solutions
CategoryAdvanced Ceramics Development
Description

Ceramic additive manufacturing offering combining proprietary ceramic ink formulation with materials testing expertise, delivered in collaboration with Hydra Manufacturing (CHAMP printer), enabling complex, high-tolerance ceramic components for aerospace and advanced manufacturing customers.

4Nuclear Waste Container Integrity Testing
CategoryNuclear Materials Testing
Description

Integrity testing service for nuclear waste storage containers, including drop tests from up to 13 meters, 3D laser surface scanning, and underwater immersion with residual gas collection, contracted by UK National Nuclear Laboratory on behalf of Sellafield Ltd.

5Silicon Nitride-Bonded Silicon Carbide (SNBSC) Materials
CategoryAdvanced Ceramics Development
Description

Low-shrinkage advanced ceramic material developed for kiln furniture in aerospace and advanced ceramics manufacturing, produced via robocasting additive manufacturing with near-complete nitriding (99.7%) and minimal dimensional change.

6Viscous Plastic Processing of Silicon Carbide
CategoryAdvanced Ceramics Development
Description

Research formulation of silicon carbide paste using viscous plastic processing with sintering aids, achieving pressureless sintering below 2000°C with 86% theoretical density for advanced ceramics.

7Fusion Energy Ceramics Research
CategoryAdvanced Ceramics Research
Description

Research contracts with UK Atomic Energy Authority (UKAEA) under the Fusion Futures Industry Capability Programme, focusing on creating advanced ceramics capable of withstanding extreme temperatures and neutron damage inside fusion machines.

8Sustainable Titanium Production (Metalysis Consortium)
CategoryAdvanced Materials Testing and Characterization
Description

Consortium participation in ESA-funded 24-month programme led by Metalysis to develop continuous sustainable titanium production using the FFC electrochemical process, with Lucideon contributing materials testing and characterization expertise for space and aerospace supply chain applications.

9AMRICC Academy Training Programmes
CategoryCeramics Training and Education
Description

Educational and training programmes for scientists and engineers in traditional and advanced ceramics, addressing the long-standing skills gap in the ceramics sector, delivered through the AMRICC Centre in Staffordshire, UK.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-01
Description

Partnership to develop and operate an in vitro cell biology laboratory in Staffordshire, UK. This collaboration creates academic rigor and research capabilities in biological testing, complementing Lucideon's commercial testing services and supporting advanced medical device testing methodologies.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-04-01
Description

Collaboration to advance ceramic additive manufacturing solutions, combining Hydra's CHAMP printer technology with Lucideon's ceramic ink formulation and materials testing expertise. The partnership leverages Hydra's in-situ green machining capability and Lucideon's access to the AMRICC Centre's processing facilities for scale-up and commercialization of complex ceramic geometries.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-03-01
Description

Consortium partner in ESA-funded 24-month programme to develop continuous sustainable titanium production using Metalysis' patented FFC Process. Lucideon contributes materials testing and characterization expertise to support scale-up of titanium production technology for space and aerospace applications.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-03-01
Description

Consortium partner in ESA titanium production project focused on developing continuous sustainable titanium production methods for Western supply chain security.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-03-01
Description

Consortium partner in ESA titanium production project contributing to development of sustainable titanium supply chain for aerospace and defense applications.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-01
Description

Awarded three research contracts by UKAEA under the Fusion Futures Industry Capability Programme. Lucideon will focus on creating advanced ceramics capable of withstanding extreme temperatures and neutron damage inside fusion machines, drawing on expertise and facilities at its Staffordshire headquarters and The AMRICC Centre.

7Science and Technology Facilities Council
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-01
Description

Key partner in AMRICC Centre, a £10m educational and research facility within the Midlands Industrial Ceramics Group's £18.27m research programme. Contributes to training programmes for scientists and engineers in the ceramics sector.

themanufacturer.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-01
Description

Key partner in AMRICC Centre contributing computational and data science capabilities to advanced ceramics research and development programmes.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-01
Description

Partner in AMRICC Academy providing specialized training programmes for scientists and engineers in both traditional and advanced ceramics, addressing long-standing skills gap in the sector.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-05-01
Description

Partner in AMRICC Centre contributing to the educational hub for ceramics sector training and skills development in Staffordshire, UK.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Engineering and scientific consulting firm combining laboratory testing, failure analysis, and expert testimony. Comparable in multidisciplinary materials failure analysis and expert-driven services.

TypeBroad incumbent
Description

Major industrial group with significant advanced ceramics and high-performance materials operations. Comparable in ceramics and materials science but operates across an enormous portfolio of construction and industrial businesses.

TypeDirect peer
Description

Medical device-focused testing and consulting organization offering biocompatibility, sterilization, and regulatory services. Directly overlaps with Lucideon's Greenville and Staffordshire medical device testing offerings.

TypeBroad incumbent
Description

Global testing services conglomerate with growing medical device and materials characterization capabilities. Comparable services but at vastly larger scale and broader portfolio.

TypeBroad incumbent
Description

Largest privately held technical ceramics manufacturer globally, serving semiconductor, medical, aerospace, and industrial customers. Comparable end-markets but at vastly larger manufacturing scale.

TypeBroad incumbent
Description

Global TIC giant with broad materials, product, and certification services across all sectors Lucideon targets. Comparable services but at vastly larger scale and broader portfolio.

TypeDirect peer
Description

French advanced materials company with strong portfolio in technical ceramics, graphite, and electrical applications. Comparable in advanced ceramics development and qualification for extreme environments.

TypeDirect peer
Description

Global materials testing and product qualification services provider with similar breadth across aerospace, medical, and industrial sectors. Closest direct comparable in materials characterization and failure analysis services.

TypeDirect peer
Description

Independent testing, consulting, and contract research firm with strong materials, medical device, and polymer testing capabilities. Directly comparable in scope and client mix to Lucideon's testing business.

TypeDirect peer
Description

UK-based manufacturer of advanced ceramics and carbon-based materials for aerospace, medical, and industrial applications. Comparable in advanced ceramics IP and sector overlap.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Lucideon

Materials Testing and Development Serviceslucideon.com

Lucideon is a UK-based development and commercialization organization providing materials science services — including medical device biocompatibility testing and advanced ceramics development for nuclear, fusion, and aerospace clients — across facilities in Staffordshire and Greenville, South Carolina.

What Lucideon does

Lucideon is a UK-headquartered development and commercialization organization (DCO) specializing in materials science and technology services, operating from Staffordshire with a newer US facility in Greenville, South Carolina. The company is organized around two principal service lines: (1) medical device biocompatibility and biological testing — including cytotoxicity, extractables and leachables, toxicological risk assessment, and implant performance testing — delivered through its Greenville lab and an in vitro cell biology laboratory in Staffordshire developed with Queen Mary University of London; and (2) advanced ceramics development and characterization, covering ceramic additive manufacturing (in partnership with Hydra Manufacturing), nuclear waste container integrity testing, proprietary ceramic ink formulations, SNBSC and silicon carbide processing R&D, and fusion-energy-grade ceramics under UKAEA contracts. Technical differentiation rests on proprietary processing IP (e.g., viscous plastic processing of SiC achieving 86% theoretical density below 2000°C, SNBSC robocasting at 99.7% nitriding) and embedded positions within UK research infrastructure such as the £18.27m Midlands Industrial Ceramics Group and AMRICC Centre.

Lucideon monetizes primarily through professional services: testing fees for medical device regulatory compliance, government and institutional research contracts (UKAEA, UKNNL, ESA consortium), and collaborative materials development engagements with industrial clients in medical devices, aerospace, and nuclear sectors. The company has no publicly disclosed pricing; engagements are scoped and contracted per project. It sells through direct enterprise engagement with engineering and procurement teams, supplemented by technical presence at industry events such as Ceramics Expo USA and the Next Generation Industry Conference. Its customer base spans medical device manufacturers (primary segment), nuclear operators and government bodies, fusion energy research organizations, and aerospace/advanced manufacturers, with notable named engagements including Sellafield Ltd (via UKNNL), UKAEA, and an ESA-funded Metalysis-led titanium consortium. The company is privately held as Lucideon Ltd, with no parent company or institutional investor identified in the available data.

Lucideon firmographics

Firmographics
Name
Lucideon
Legal name
Lucideon Ltd
Website
https://lucideon.com
Company type
Private
Founded year
1948
Operating status
Operating
Headcount range
101–250 employees
Short description
Lucideon is a UK-based development and commercialization organization providing materials science services — including medical device biocompatibility testing and advanced ceramics development for nuclear, fusion, and aerospace clients — across facilities in Staffordshire and Greenville, South Carolina.
Ownership category
akta.pro rank

Where Lucideon is headquartered

Location

Headquarters

HQ city
Stafford
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Lucideon business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Biocompatibility Testing Services: Comprehensive testing services for medical devices including cytotoxicity, extractables and leachables testing, toxicological risk assessment, and advanced implant performance assessments. Revenue generated through testing fees for regulatory compliance.
  2. Research Contracts: Government and institutional research contracts including work for UK Atomic Energy Authority under Fusion Futures Industry Capability Programme and UK National Nuclear Laboratory for nuclear industry testing.
  3. Materials Development and Consulting: Collaborative materials development including ceramic additive manufacturing solutions and advanced ceramics development for specialized applications in aerospace and industrial manufacturing.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Lucideon product offering

Product offering

Core offering

Lucideon is a development and commercialization organization that provides advanced materials testing, characterization, and development services. Its core offerings include medical device biocompatibility testing (cytotoxicity, extractables and leachables, toxicological risk assessment, implant performance) through laboratories in Greenville, SC and Staffordshire, UK, and advanced ceramics research covering ceramic additive manufacturing, nuclear waste container integrity testing, and fusion-energy ceramics for UKAEA. Revenue is generated primarily through project-based testing fees and collaborative materials development contracts with enterprise and government clients.

Product overview

Lucideon is an international technology company offering a portfolio of advanced materials testing and development services. The company operates two complementary core offerings: (1) medical device biocompatibility testing through its laboratories in Greenville, South Carolina and Staffordshire, UK, providing cytotoxicity, extractables and leachables testing, toxicological risk assessment, and implant performance assessments; and (2) advanced ceramics development including ceramic additive manufacturing solutions (via Hydra collaboration), nuclear waste container integrity testing, SNBSC kiln furniture materials, viscous plastic processing of silicon carbide, and fusion energy ceramics research for UKAEA. Additionally, Lucideon participates in the Metalysis ESA consortium for sustainable titanium production and supports the AMRICC Academy for ceramics sector training.

Differentiator

Problem solved

Functional benefit

Products and services

  • Biocompatibility Testing Laboratory - Greenville State-of-the-art facility in Greenville, South Carolina providing comprehensive medical device biocompatibility testing — including cytotoxicity, extractables and leachables testing, toxicological risk assessment, and advanced implant performance assessments — for medical device manufacturers needing to verify biological safety and meet FDA and international regulatory requirements.
  • In Vitro Cell Biology Laboratory Complementary in vitro cell biology laboratory in Staffordshire, UK, developed in partnership with Queen Mary University of London's School of Engineering and Materials Science, supporting advanced biological testing for medical device manufacturers.
  • Ceramic Additive Manufacturing Solutions Ceramic additive manufacturing offering combining proprietary ceramic ink formulation with materials testing expertise, delivered in collaboration with Hydra Manufacturing (CHAMP printer), enabling complex, high-tolerance ceramic components for aerospace and advanced manufacturing customers.
  • Nuclear Waste Container Integrity Testing Integrity testing service for nuclear waste storage containers, including drop tests from up to 13 meters, 3D laser surface scanning, and underwater immersion with residual gas collection, contracted by UK National Nuclear Laboratory on behalf of Sellafield Ltd.
  • Silicon Nitride-Bonded Silicon Carbide (SNBSC) Materials Low-shrinkage advanced ceramic material developed for kiln furniture in aerospace and advanced ceramics manufacturing, produced via robocasting additive manufacturing with near-complete nitriding (99.7%) and minimal dimensional change.
  • Viscous Plastic Processing of Silicon Carbide Research formulation of silicon carbide paste using viscous plastic processing with sintering aids, achieving pressureless sintering below 2000°C with 86% theoretical density for advanced ceramics.
  • Fusion Energy Ceramics Research Research contracts with UK Atomic Energy Authority (UKAEA) under the Fusion Futures Industry Capability Programme, focusing on creating advanced ceramics capable of withstanding extreme temperatures and neutron damage inside fusion machines.
  • Sustainable Titanium Production (Metalysis Consortium) Consortium participation in ESA-funded 24-month programme led by Metalysis to develop continuous sustainable titanium production using the FFC electrochemical process, with Lucideon contributing materials testing and characterization expertise for space and aerospace supply chain applications.
  • AMRICC Academy Training Programmes Educational and training programmes for scientists and engineers in traditional and advanced ceramics, addressing the long-standing skills gap in the ceramics sector, delivered through the AMRICC Centre in Staffordshire, UK.

Quantifiable outcome

  • Near-complete nitriding (99.7%) achieved for SNBSC ceramic materials via additive manufacturing
  • +1 more outcomes

Companies that use Lucideon

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Lucideon technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Lucideon partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • Queen Mary University of London (School of Engineering and Materials Science)coreStrategic or Co-development Partner · 1 May 2026Partnership to develop and operate an in vitro cell biology laboratory in Staffordshire, UK. This collaboration creates academic rigor and research capabilities in biological testing, complementing Lucideon's commercial testing services and supporting advanced medical device testing methodologies.
  • Hydra ManufacturingcoreStrategic or Co-development Partner · 1 April 2026Collaboration to advance ceramic additive manufacturing solutions, combining Hydra's CHAMP printer technology with Lucideon's ceramic ink formulation and materials testing expertise. The partnership leverages Hydra's in-situ green machining capability and Lucideon's access to the AMRICC Centre's processing facilities for scale-up and commercialization of complex ceramic geometries.
  • MetalysisminorStrategic or Co-development Partner · 1 March 2026Consortium partner in ESA-funded 24-month programme to develop continuous sustainable titanium production using Metalysis' patented FFC Process. Lucideon contributes materials testing and characterization expertise to support scale-up of titanium production technology for space and aerospace applications.
  • TTP PlcminorStrategic or Co-development Partner · 1 March 2026Consortium partner in ESA titanium production project focused on developing continuous sustainable titanium production methods for Western supply chain security.
  • NCHG LtdminorStrategic or Co-development Partner · 1 March 2026Consortium partner in ESA titanium production project contributing to development of sustainable titanium supply chain for aerospace and defense applications.
  • UK Atomic Energy Authority (UKAEA)coreStrategic or Co-development Partner · 1 December 2025Awarded three research contracts by UKAEA under the Fusion Futures Industry Capability Programme. Lucideon will focus on creating advanced ceramics capable of withstanding extreme temperatures and neutron damage inside fusion machines, drawing on expertise and facilities at its Staffordshire headquarters and The AMRICC Centre.
  • Science and Technology Facilities CouncilcoreStrategic or Co-development Partner · 1 May 2025Key partner in AMRICC Centre, a £10m educational and research facility within the Midlands Industrial Ceramics Group's £18.27m research programme. Contributes to training programmes for scientists and engineers in the ceramics sector.
  • Hartree CentrecoreStrategic or Co-development Partner · 1 May 2025Key partner in AMRICC Centre contributing computational and data science capabilities to advanced ceramics research and development programmes.
  • Ceramic Technology AcademycoreStrategic or Co-development Partner · 1 May 2025Partner in AMRICC Academy providing specialized training programmes for scientists and engineers in both traditional and advanced ceramics, addressing long-standing skills gap in the sector.
  • Axia Value SolutionsminorStrategic or Co-development Partner · 1 May 2025Partner in AMRICC Centre contributing to the educational hub for ceramics sector training and skills development in Staffordshire, UK.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Lucideon competitors and assessment

Company assessment

Direct peers

  • Exponent: Engineering and scientific consulting firm combining laboratory testing, failure analysis, and expert testimony. Comparable in multidisciplinary materials failure analysis and expert-driven services.
  • NAMSA: Medical device-focused testing and consulting organization offering biocompatibility, sterilization, and regulatory services. Directly overlaps with Lucideon's Greenville and Staffordshire medical device testing offerings.
  • Mersen: French advanced materials company with strong portfolio in technical ceramics, graphite, and electrical applications. Comparable in advanced ceramics development and qualification for extreme environments.
  • Element Materials Technology: Global materials testing and product qualification services provider with similar breadth across aerospace, medical, and industrial sectors. Closest direct comparable in materials characterization and failure analysis services.
  • Smithers Group: Independent testing, consulting, and contract research firm with strong materials, medical device, and polymer testing capabilities. Directly comparable in scope and client mix to Lucideon's testing business.
  • Morgan Advanced Materials: UK-based manufacturer of advanced ceramics and carbon-based materials for aerospace, medical, and industrial applications. Comparable in advanced ceramics IP and sector overlap.

Broad incumbents

  • Saint-Gobain: Major industrial group with significant advanced ceramics and high-performance materials operations. Comparable in ceramics and materials science but operates across an enormous portfolio of construction and industrial businesses.
  • Eurofins Scientific: Global testing services conglomerate with growing medical device and materials characterization capabilities. Comparable services but at vastly larger scale and broader portfolio.
  • CoorsTek: Largest privately held technical ceramics manufacturer globally, serving semiconductor, medical, aerospace, and industrial customers. Comparable end-markets but at vastly larger manufacturing scale.
  • Intertek Group: Global TIC giant with broad materials, product, and certification services across all sectors Lucideon targets. Comparable services but at vastly larger scale and broader portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Lucideon social profiles

Digital presence

Lucideon financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Lucideon leadership team

Management profile

Number of profiles

Lucideon funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Lucideon M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lucideon

What does Lucideon do?

Lucideon is a development and commercialization organization that provides advanced materials testing, characterization, and development services. Its core offerings include medical device biocompatibility testing (cytotoxicity, extractables and leachables, toxicological risk assessment, implant performance) through laboratories in Greenville, SC and Staffordshire, UK, and advanced ceramics research covering ceramic additive manufacturing, nuclear waste container integrity testing, and fusion-energy ceramics for UKAEA. Revenue is generated primarily through project-based testing fees and collaborative materials development contracts with enterprise and government clients.

Is Lucideon a public or private company?

Lucideon is a private company. It is classified as unknown and is currently operating.

When was Lucideon founded?

Lucideon was founded in 1948. It employs 101 to 250 people.

Where is Lucideon based?

Lucideon is headquartered in Stafford, United Kingdom, in the Europe region.

How does Lucideon make money?

Three revenue lines are on record. Biocompatibility Testing Services are the primary driver. The others are research Contracts and materials Development and Consulting.

Who are Lucideon's main competitors?

Direct peers on record are Exponent, NAMSA, Mersen, Element Materials Technology, Smithers Group and Morgan Advanced Materials. Broad incumbents are Saint-Gobain, Eurofins Scientific, CoorsTek and Intertek Group.

Does Lucideon have an API?

No public API is recorded for Lucideon.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
CompositesworldLucideon to Establish Sovereign U.K. Manufacturing of CMC for Aerospace, Defense and NuclearLucideon is proposing the establishment of a sovereign U.K. manufacturing facility for ceramic matrix composite (CMC) materials to support the aerospace, defense, and nuclear sectors. The initiative involves new companies incorporated by Lucideon and requires an estimated £500 million investment over 7-10 years, including approximately £200 million in government funding.The UK£500m plans unveiled for Staffordshire ceramics manufacturing centreLucideon has unveiled plans for a £500 million ceramic matrix composites manufacturing centre located at the Keele University Science Park in Staffordshire. The project is described by Chief Executive Tony Kinsella as marking a new era and the rebirth of the advanced ceramics industry in the UK.InsidermediaPlans unveiled for £500m manufacturing centre in Staffordshire - “the journey has now started to make the UK a leader in high-growth advanced material technologies”Lucideon has unveiled plans for a £500m Ceramic Matrix Composite manufacturing facility at Keele University Science Park in Staffordshire to establish sovereign production capabilities for the UK aerospace, defence, and nuclear sectors. The project involves new subsidiaries, Oxide Ceramic Systems and Non-Oxide Ceramic Systems, and requires approximately £200m in government investment alongside private funding over seven to ten years. This initiative aims to eliminate supply chain vulnerabilities and strengthen national industrial resilience through collaboration with the AMRICC Centre.The EngineerAMRICC academy launches to boost ceramics skillsThe AMRICC Academy has launched to address skills gaps in the ceramics sector by providing specialized training programs for scientists and engineers. Established within the £10 million AMRICC Centre in Staffordshire, the initiative is supported by key partners including Lucideon, the Science and Technology Facilities Council, and the Hartree Centre.GoogleLucideon and MTC partner on advanced ceramicsLucideon has signed a Memorandum of Understanding with the Manufacturing Technology Centre (MTC) in Coventry to jointly develop advanced ceramics and ceramic matrix composites, covering formulation, joining, pressing, additive manufacturing and sintering techniques including flash sintering and hot isostatic pressing. Lucideon will lead materials analysis and evaluation, while MTC handles system design and industrial-scale implementation, with applications in energy, aerospace and defence.The EngineerLucideon and MTC partner on advanced ceramicsLucideon has entered into a strategic partnership with the Manufacturing Technology Centre (MTC) through a newly signed Memorandum of Understanding to advance next-generation ceramic materials and manufacturing technologies. The collaboration will focus on flash sintering, hot isostatic pressing, additive manufacturing, and multi-material joining, targeting energy, aerospace, and defence sectors while addressing industrial challenges in energy resilience, sustainability, and Net Zero. The partnership will leverage the AMRICC Centre, the UK's only advanced ceramics pilot-scale facility, to accelerate commercialization from lab-scale innovation to market-ready solutions.TodaysmedicaldevelopmentsLucideon pursues development of safer medical devices with biocompatibility lab launchInternational technology company Lucideon has launched a state-of-the-art biocompatibility testing laboratory in Greenville, South Carolina, which became fully operational in May 2026. The facility provides comprehensive testing services including cytotoxicity, extractables and leachables testing, toxicological risk assessment, and advanced implant performance assessments to ensure medical devices are safe for human biological interaction. The lab works in tandem with Lucideon's in vitro cell biology laboratory in the UK, developed in partnership with Queen Mary University of London's School of Engineering and Materials Science, creating a global footprint for medical device testing and compliance support.BriefglanceNew Lucideon Lab Aims to Secure the Future of Medical Device SafetyLucideon has opened a new biocompatibility laboratory in Greenville, South Carolina, to enhance safety standards for the global medical device industry. The facility consolidates testing services to streamline regulatory compliance and accelerate product development, addressing the growing complexity of medical technology. It is part of Lucideon's broader strategy to serve the international market and support innovation in a regional life sciences hub.GlobeNewswireLucideon launches new biocompatibility lab to support a new era in patient safetyInternational technology company Lucideon launched a pioneering biocompatibility laboratory in Greenville, South Carolina, in May 2026, providing comprehensive testing services for medical devices to ensure safe interaction with human biological systems. The facility offers full-spectrum testing including cytotoxicity, extractables and leachables analysis, toxicological risk assessment, and advanced materials characterization to help device manufacturers meet regulatory requirements. Lucideon also operates a complementary in vitro cell biology laboratory in Staffordshire, UK, developed in partnership with Queen Mary University of London, creating a global footprint for medical device testing and compliance services.Market ScoopAdvanced Structural Ceramics MarketThe global advanced structural ceramics market is projected to grow from USD 9.3 billion in 2025 to USD 17.2 billion by 2035, representing a compound annual growth rate of 6.3%, with alumina material type commanding approximately 32.8% market share and industrial applications accounting for 27.5% of total demand. Asia Pacific maintains dominant market positioning with a 51.3% revenue share, driven by concentrated electronics, automotive, and industrial manufacturing ecosystems in China, Japan, South Korea, and India. Key market developments include an April 2026 collaboration between Hydra Manufacturing and Lucideon to advance ceramic additive manufacturing solutions, and a March 2026 memorandum of understanding between Oak Ridge National Laboratory and General Atomics Electromagnetic Systems for ceramic matrix composite materials development for extreme environment applications.